Irish headquartered international project delivery firm PM Group is creating 400 new jobs this year across several disciplines including architecture, engineering, construction, data analytics, project controls and Environmental.

200 of these new positions will be based in Ireland.

The company said that recruitment for the new positions is already underway.

PM Group has a workforce of 3,200 people in Europe, North America and Asia. It provides complex design, construction and delivery solutions to clients in pharma, food, mission critical, medtech and advanced manufacturing technology sectors.

The Group is employee owned with over 1,000 people holding shares, up 15% on the previous year.

Reporting results for 2020, the company said it continued to expand its target market into Europe and the US with major projects undertaken for MSD, Bayer, J&J, Johnson Matthey and Facebook.

PM Group said its UK operation was up on the previous year, accounting for 9% of 2020 Group revenues. While pharma was strong it said there were some delays experienced in other sectors given Covid-19 and Brexit uncertainties.

In Mainland Europe, which accounted for 29% of revenues, the Group experienced growth in its operations in Belgium, the Netherlands, Denmark, Poland and Switzerland.

PM Group has also recently opened a new operation in Frankfurt to support its work in the German market.

In the US, PM Group said its teams in Boston and San Francisco delivered further growth for key clients and recently set up a third operation in Philadelphia.

Meanwhile, acivity in Asia accounted for 9% of Group revenue in 2020. Strong performance in China related to the delivery of projects for MSD, AstraZeneca, Geneception, Pernod Ricard and Nike.

The Singapore office delivered significant projects for PepsiCo, Roche, Novartis and Boston Scientific.

The Group's Bangalore operation, which now has more than 100 people, supports projects across all international business units as well as providing shared services.

The company today reported operating profits of €34.8m in 2020, an increase of 30% on 2019. PM Group's overall revenue increased to €398m last year, up 16%.

It said its net assets increased to €111m, up from €85m in 2019, which combined with minimal debt, underpins its ability to continue to invest in development and growth.

Dave Murphy, chief executive of PM Group, said that despite the enormous challenges posed by the global pandemic, the company's clients have continued to invest in developing their facilities and capacity right around the world.

"Many of the sectors and projects with which we are currently engaged, are actively dealing with the consequences of the pandemic," Mr Murphy said.

Dave Murphy, CEO of the PM Group; Rosita Fennell, CFO and Brendan Jennings, Chair of the company

"Therapeutics and vaccine manufacturing, food and beverage processing, medical devices and diagnostics as well as data centres are attracting significant investment to meet evolving market needs. Indeed, Pharma is a powerhouse sector for us with two-thirds of overall revenues generated in 2020 associated with the sector," the CEO said.

Mr Murphy said that the surge in investment has carried into 2021, with international projects now accounting for more than 50% of Group activity for the first time in its history.

"The growth of the business has created new opportunities for increasing employment, and we are pleased to be announcing 400 new jobs across a range of disciplines in Ireland and overseasm" he added.

"The attraction of working with experienced colleagues on exciting international projects for world leading organisations, combined with the potential to become an owner of PM Group in time, is a strong magnet for talent," he added.